Cardiac myocyte differentiation

Cardiac myocyte differentiation is a **biological process** in which precursor cells acquire the specialized features of cardiac muscle cells—also known as cardiomyocytes. This process involves a sequence of gene expression changes and cellular events that begin with mesodermal specification and progress through cardiac progenitor stages to fully differentiated cardiomyocytes. Key molecular markers include transcription factors such as NKX2.5, GATA4, MEF2C; structural proteins like cardiac troponins and myosins; and ion channels essential for electrical activity[1][2][4]. The process is regulated by signaling pathways including Wnt/β-catenin, BMP/TGFβ superfamily members, Notch, Hippo, and others[6]. Differentiation protocols using human pluripotent stem cells often employ small molecules or growth factors to modulate these pathways for efficient generation of functional cardiomyocytes in vitro[4]. While critical for heart development and regenerative medicine research—including drug screening and disease modeling—cardiac myocyte differentiation itself is not a therapeutic target but rather a developmental event or pathway[8]. **Note:** "Cardiac myocyte differentiation" refers to a biological process rather than an individual molecule or receptor. It does not represent a discrete druggable target such as an enzyme or receptor protein; therefore it should be flagged as incorrect if used in the context of molecular therapeutic targets[8].

Other names

Cardiomyocyte differentiationCardiac muscle cell differentiationHeart muscle cell differentiation